Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Gene-targeted therapy.

Artykuły w czasopismach na temat „Gene-targeted therapy”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Gene-targeted therapy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Hart, I. R., and R. G. Vile. "Targeted gene therapy." British Medical Bulletin 51, no. 3 (1995): 647–55. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072984.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Katz, Stephen I. "Prospects for targeted gene therapy." Clinical and Experimental Dermatology 25, no. 2 (2000): 157. http://dx.doi.org/10.1046/j.1365-2230.2000.0604c.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Miller, Nicholas, and Richard Vile. "Targeted vectors for gene therapy." FASEB Journal 9, no. 2 (1995): 190–99. http://dx.doi.org/10.1096/fasebj.9.2.7781922.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Harris, Jonathan D., and Nick R. Lemoine. "Strategies for targeted gene therapy." Trends in Genetics 12, no. 10 (1996): 400–405. http://dx.doi.org/10.1016/0168-9525(96)40031-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Dougherty, Graeme J., Peter D. Davis, and Shona T. Dougherty. "Vascular-targeted cancer gene therapy." Expert Opinion on Biological Therapy 4, no. 12 (2004): 1911–20. http://dx.doi.org/10.1517/14712598.4.12.1911.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Węgrzyn, Alicja. "Gene expression-targeted isoflavone therapy." IUBMB Life 64, no. 4 (2012): 307–15. http://dx.doi.org/10.1002/iub.1007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Parekh-Olmedo, H., L. Ferrara, E. Brachman, and E. B. Kmiec. "Gene therapy progress and prospects: targeted gene repair." Gene Therapy 12, no. 8 (2005): 639–46. http://dx.doi.org/10.1038/sj.gt.3302511.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Rots, M. G., D. T. Curiel, W. R. Gerritsen, and H. J. Haisma. "Targeted cancer gene therapy: the flexibility of adenoviral gene therapy vectors." Journal of Controlled Release 87, no. 1-3 (2003): 159–65. http://dx.doi.org/10.1016/s0168-3659(02)00360-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

KONISHI, Hiroyasu, and Tetsuichiro MUTO. "Targeted Gene Therapy for Colorectal Cancer." Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) 24, no. 1 (1999): 1–7. http://dx.doi.org/10.4030/jjcs1979.24.1_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Rocconi, Rodney, T. Numnum, Mariam Stoff-Khalili, Sharmila Makhija, Ronald Alvarez, and David Curiel. "Targeted Gene Therapy for Ovarian Cancer." Current Gene Therapy 5, no. 6 (2005): 643–53. http://dx.doi.org/10.2174/156652305774964668.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Unger, E. C., and R. Sweitzer. "Ultrasound-targeted gene and drug therapy." Ultrasound in Medicine & Biology 29, no. 5 (2003): S41. http://dx.doi.org/10.1016/s0301-5629(03)00211-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Shi, Qizhen. "Platelet-Targeted Gene Therapy for Hemophilia." Molecular Therapy - Methods & Clinical Development 9 (June 2018): 100–108. http://dx.doi.org/10.1016/j.omtm.2018.01.011.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Colombo, Mario P., and Giorgio Parmiani. "Tumor-cell-targeted cytokine gene therapy." Immunology Today 12, no. 7 (1991): 249–50. http://dx.doi.org/10.1016/0167-5699(91)90044-t.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Binley, Katie. "Exploiting hypoxia for targeted gene therapy." Gene Therapy and Regulation 2, no. 1 (2003): 59–75. http://dx.doi.org/10.1163/156855803762295431.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Bachtarzi, Houria, Mark Stevenson, and Kerry Fisher. "Cancer gene therapy with targeted adenoviruses." Expert Opinion on Drug Delivery 5, no. 11 (2008): 1231–40. http://dx.doi.org/10.1517/17425240802507636.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Weichselbaum, Ralph R., Dennis E. Hallahan, Vikas P. Sukhatme, and Donald W. Kufe. "Gene therapy targeted by ionizing radiation." International Journal of Radiation Oncology*Biology*Physics 24, no. 3 (1992): 565–67. http://dx.doi.org/10.1016/0360-3016(92)91075-x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Curiel, D. T. "TARGETED GENE DELIVERY TO ACCOMPLISH GENE THERAPY FOR CANCER." Journal of Immunotherapy 16, no. 3 (1994): 235. http://dx.doi.org/10.1097/00002371-199410000-00014.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Cristiano, Richard J. "Targeted non-viral gene delivery for cancer gene therapy." Frontiers in Bioscience 3, no. 4 (1998): d1161–1170. http://dx.doi.org/10.2741/a352.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Boggs, Sallie S. "Targeted gene modification for gene therapy of stem cells." International Journal of Cell Cloning 8, no. 2 (1990): 80–95. http://dx.doi.org/10.1002/stem.5530080202.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Kim, Jayoung, David R. Wilson, Camila G. Zamboni, and Jordan J. Green. "Targeted polymeric nanoparticles for cancer gene therapy." Journal of Drug Targeting 23, no. 7-8 (2015): 627–41. http://dx.doi.org/10.3109/1061186x.2015.1048519.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Davies, D. Mark. "Tuberous sclerosis: from gene to targeted therapy." Clinical Medicine 12, Suppl 6 (2012): s7—s10. http://dx.doi.org/10.7861/clinmedicine.12-6-s7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Altwaijry, Najla, Sukrut Somani, and Christine Dufès. "Targeted nonviral gene therapy in prostate cancer." International Journal of Nanomedicine Volume 13 (September 2018): 5753–67. http://dx.doi.org/10.2147/ijn.s139080.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

King, Gwendalyn, James Curtin, Marianela Candolfi, Kurt Kroeger, Pedro Lowenstein, and Maria Castro. "Gene Therapy and Targeted Toxins for Glioma." Current Gene Therapy 5, no. 6 (2005): 535–57. http://dx.doi.org/10.2174/156652305774964631.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

G. Castro, Maria, Marianela Candolfi, Kurt M. Kroeger, et al. "Gene Therapy and Targeted Toxins for Glioma." Current Gene Therapy 11, no. 3 (2011): 155–80. http://dx.doi.org/10.2174/156652311795684722.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Li, L.-Y., H.-Y. Dai, F.-L. Yeh, et al. "Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy." Oncogene 30, no. 15 (2010): 1773–83. http://dx.doi.org/10.1038/onc.2010.558.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Alexander, J. J., and W. W. Hauswirth. "Prospects for retinal cone-targeted gene therapy." Drug News & Perspectives 21, no. 5 (2008): 267. http://dx.doi.org/10.1358/dnp.2008.21.5.1223972.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Starling, Shimona. "Targeted aspartoacylase gene therapy reverts Canavan disease." Nature Reviews Neurology 14, no. 1 (2017): 4. http://dx.doi.org/10.1038/nrneurol.2017.170.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Park, Kinam. "Cornea-targeted gene therapy using adenovirus vector." Journal of Controlled Release 181 (May 2014): 53. http://dx.doi.org/10.1016/j.jconrel.2014.03.042.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Waehler, Reinhard, Stephen J. Russell, and David T. Curiel. "Engineering targeted viral vectors for gene therapy." Nature Reviews Genetics 8, no. 8 (2007): 573–87. http://dx.doi.org/10.1038/nrg2141.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Zylberberg, C., K. Gaskill, S. Pasley, and S. Matosevic. "Engineering liposomal nanoparticles for targeted gene therapy." Gene Therapy 24, no. 8 (2017): 441–52. http://dx.doi.org/10.1038/gt.2017.41.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Aravalli, Rajagopal N., John D. Belcher, and Clifford J. Steer. "Liver-targeted gene therapy: Approaches and challenges." Liver Transplantation 21, no. 6 (2015): 718–37. http://dx.doi.org/10.1002/lt.24122.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Alexander, J. J., and W. W. Hauswirth. "Prospects for retinal cone-targeted gene therapy." Drug News & Perspectives 21, no. 5 (2008): 267. http://dx.doi.org/10.1358/dnp.2008.21.5.1219012.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Dirven, Clemens M. F., Jacques Grill, Martine L. M. Lamfers, et al. "Gene therapy for meningioma: improved gene delivery with targeted adenoviruses." Journal of Neurosurgery 97, no. 2 (2002): 441–49. http://dx.doi.org/10.3171/jns.2002.97.2.0441.

Pełny tekst źródła
Streszczenie:
Object. Due to their surgical inaccessibility or aggressive behavior, some meningiomas cannot be cured with current treatment strategies. Gene therapy is an emerging strategy for the treatment of brain tumors, which the authors investigated to determine whether adenoviruses could be used for gene transfer in meningioma cells. Methods. The presence of the high-affinity Coxsackievirus and adenovirus receptor (CAR) for adenovirus type 5, as well as endothelial growth factor receptor (EGFR) and alphav integrins (ITGAVs), were analyzed in primary tumors by using immunohistochemical studies and in p
Style APA, Harvard, Vancouver, ISO itp.
34

Margarita, Shuvalova, and Shokhina Arina. "Specific Endothelial Promoters for Targeted Gene Expression and Gene Therapy." Research Journal of Biotechnology 20, no. 6 (2025): 157–64. https://doi.org/10.25303/206rjbt1570164.

Pełny tekst źródła
Streszczenie:
Tissue-specific promoters play a crucial role in both fundamental research and practical applications. They allow targeted gene expression only in specific cell types, minimizing off-target effects on neighboring cells. In the context of gene therapy for vascular diseases, the use of tissue-specific promoters becomes particularly important to minimize non-targeted transgene expression and potential side effects. Endothelial cells, which line blood vessels and regulate the exchange of substances between blood and organs, are potential targets for gene therapy in certain vascular diseases. Sever
Style APA, Harvard, Vancouver, ISO itp.
35

Liu, Jinlu, Ling Yang, Xin Yuan, et al. "Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma." International Journal of Nanomedicine Volume 16 (November 2021): 7697–709. http://dx.doi.org/10.2147/ijn.s331519.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Pranjol, Md, and Amin Hajitou. "Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy." Viruses 7, no. 1 (2015): 268–84. http://dx.doi.org/10.3390/v7010268.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Lin, X., L. Tao, and D. Tang. "Gene Therapy, A Targeted Treatment for Diabetic Nephropathy." Current Medicinal Chemistry 20, no. 30 (2013): 3774–84. http://dx.doi.org/10.2174/09298673113209990183.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

R. Dass, Mark A. Burton, Crispin. "Microsphere-Mediated Targeted Gene Therapy of Solid Tumors." Drug Delivery 6, no. 4 (1999): 243–52. http://dx.doi.org/10.1080/107175499266832.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Cutrera, Jeffry, Denada Dibra, Arun Satelli, Xuexing Xia, and Shulin Li. "Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy." Mediators of Inflammation 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/378971.

Pełny tekst źródła
Streszczenie:
The safest and most effective cytokine therapies require the favorable accumulation of the cytokine in the tumor environment. While direct treatment into the neoplasm is ideal, systemic tumor-targeted therapies will be more feasible. Electroporation-mediated transfection of cytokine plasmid DNA including a tumor-targeting peptide-encoding sequence is one method for obtaining a tumor-targeted cytokine produced by the tumor-bearing patient’s tissues. Here, the impact on efficacy of the location of targeting peptide, choice of targeting peptide, tumor histotype, and cytokine utilization are studi
Style APA, Harvard, Vancouver, ISO itp.
40

Hawkins, RE, HA Whittington, SJ Watkins, and DE Gilham. "Antibodies: from genes to targeted cancer gene therapy." Gene Therapy 5, no. 12 (1998): 1581–83. http://dx.doi.org/10.1038/sj.gt.3300788.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Mairs, Robert J., Natasha E. Fullerton, Emilio Cosimo, and Marie Boyd. "Gene manipulation to enhance MIBG-targeted radionuclide therapy." Nuclear Medicine and Biology 32, no. 7 (2005): 749–53. http://dx.doi.org/10.1016/j.nucmedbio.2005.03.011.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Brown, M., M. Boyd, A. Livingston, R. Mairs, and D. Kirk. "Targeted gene therapy of prostate cancer cell lines." European Urology Supplements 2, no. 1 (2003): 221. http://dx.doi.org/10.1016/s1569-9056(03)80863-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Monfort, D. A., and P. Koria. "Recombinant elastin-based nanoparticles for targeted gene therapy." Gene Therapy 24, no. 10 (2017): 610–20. http://dx.doi.org/10.1038/gt.2017.54.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Tepper, Deborah E. "Calcitonin Gene-Related Peptide Targeted Therapy for Migraine." Headache: The Journal of Head and Face Pain 56, no. 2 (2016): 447–48. http://dx.doi.org/10.1111/head.12759.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Ghali, Shadi, Marlese P. Dempsey, Deirdre M. Jones, Raymond H. Grogan, Peter E. Butler, and Geoffrey C. Gurtner. "Plastic Surgical Delivery Systems for Targeted Gene Therapy." Annals of Plastic Surgery 60, no. 3 (2008): 323–32. http://dx.doi.org/10.1097/sap.0b013e31806917b0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Mauro, Michael J., and Brian J. Druker. "STI571: A gene product-targeted therapy for leukemia." Current Oncology Reports 3, no. 3 (2001): 223–27. http://dx.doi.org/10.1007/s11912-001-0054-z.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Moscoso, Carlos G., and Clifford J. Steer. "Liver targeted gene therapy: Insights into emerging therapies." Drug Discovery Today: Technologies 34 (December 2019): 9–19. http://dx.doi.org/10.1016/j.ddtec.2020.11.001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Nicola, Juan Pablo, and Christopher J. LaRocca. "Sodium iodide symporter-targeted gene therapy in glioblastoma." Molecular Therapy - Oncolytics 28 (March 2023): 44–45. http://dx.doi.org/10.1016/j.omto.2022.12.004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Dana Jones, Susan, and Wayne A. Marasco. "Antibodies for targeted gene therapy: extracellular gene targeting and intracellular expression." Advanced Drug Delivery Reviews 31, no. 1-2 (1998): 153–70. http://dx.doi.org/10.1016/s0169-409x(97)00099-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Tian, Peikun, Shengjun Ren, Changchun Ren, et al. "A novel receptor-targeted gene delivery system for cancer gene therapy." Science in China Series C: Life Sciences 42, no. 2 (1999): 216–24. http://dx.doi.org/10.1007/bf02880059.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!